Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 833 matching records.
833 results — page 1 of 35
- Level DAnimal StudyPubMed
Neuroprotective Potential of Conditioned Medium from Adipose and Liver Mesenchymal Stem Cells in a Rat Model of Global Cerebral Ischemia-reperfusion Injury.
Animal Study on Stroke Research, published in Curr Mol Med (2026) — summary generated from the PubMed abstract.
- 2026
Curr Mol Med - Level DLaboratory StudyEurope PMC
PET/EVOH nonwoven fabrics support <i>in vitro</i> expansion of mesenchymal stem cells with high differentiation potential
Laboratory Study, published in Regen Ther (2026) — summary generated from the PubMed abstract.
- 2026
Regen Ther - Level DAnimal StudyPubMed
Cyclophosphamide: Potential Hepatorenal Toxicity and the Possible Therapeutic Role of Mesenchymal Stem Cell-Derived Exosomes in Wistar Rats.
Animal Study on Chronic Inflammation, published in J Biochem Mol Toxicol (2026) — summary generated from the PubMed abstract.
- 2026
J Biochem Mol Toxicol - Level DLaboratory StudyPubMed
Therapeutic Potential of Mesenchymal Stem Cells in Pediatric Kidney Disorders: A Comprehensive Review.
Laboratory Study on Chronic Kidney Disease, Acute Kidney Injury, Immune Modulation, published in Health Sci Rep (2026) — summary generated from the PubMed abstract.
- 2026
Health Sci Rep - Level DNarrative ReviewEurope PMC
Activation of Nrf2 with natural flavonoids and mesenchymal stromal/stem cells: mechanisms and therapeutic potential for inflammatory diseases
Narrative Review on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level BClinical TrialPubMed
Mesenchymal stem cell-derived exosomes in myocardial infarction repair: therapeutic potential and scaffold-based delivery strategies.
Clinical Trial on Cardiovascular Disease, published in Front Pharmacol (2026) — summary generated from the PubMed abstract.
- 2026
Front Pharmacol1 citations - Level BClinical TrialEurope PMC
Therapeutic potential of mesenchymal stem cells in ocular degenerative disorders
Clinical Trial on Immune Modulation, published in J Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
J Transl Med - Level DAnimal StudyEurope PMC
Therapeutic Potential of Bone Marrow- and Ovarian/Endometrium-Derived Mesenchymal Stem Cells in Regulating Ovarian Function in a Streptozotocin-Induced Diabetes Mellitus Rat Model
Animal Study on Hair & Scalp, Systemic / IV, published in Reprod Sci (2026) — summary generated from the PubMed abstract.
- 2026
Reprod Sci - Level ASystematic ReviewPubMed
In vitro derivation of human brown adipose tissue from pluripotent and mesenchymal stem cell sources: A systematic review of genetic and non-genetic differentiation strategies.
Systematic Review, published in Differentiation (2026) — summary generated from the PubMed abstract.
- 2026
Differentiation - Level BRandomized Controlled TrialPubMed
Comparing the potential efficacy of stromal vascular fraction and adipose mesenchymal stem cell-derived exosomes in a rat model of chromium-induced thyroid dysfunction.
Randomized Controlled Trial with a reported sample of 10 on Chronic Inflammation, published in Tissue Cell (2026) — summary generated from the PubMed abstract.
- 2026
- n = 10
Tissue Cell - Level DLaboratory StudyPubMed
Maternal obesity alters adipogenic potential and mitochondrial maximal respiration in infant mesenchymal stem cells.
Laboratory Study on Hip, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Therapeutic potential of mesenchymal stromal cells in COVID-19: a meta-analysis of clinical trials conducted since the pandemic onset
Meta-analysis with a reported sample of 1080 on Chronic Inflammation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
- n = 1080
Stem Cell Res Ther - Level DLaboratory StudyPubMed
In vitro exploration of the therapeutic potential of mesenchymal stem cell conditioned medium in endometriosis treatment by targeting apoptosis and cellular migration.
Laboratory Study, published in Int J Reprod Biomed (2026) — summary generated from the PubMed abstract.
- 2026
Int J Reprod Biomed - Level CProspective StudyPubMed
Grape Pomace Polyphenolic Extract Promotes Osteogenic Differentiation in Human Mesenchymal Stem Cells Through Activation of RUNX2 and NRF2 Transcription Factors: A Potential Natural Strategy for Osteoporosis Prevention.
Prospective Study, published in Biology (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Biology (Basel) - Level DAnimal StudyPubMed
Sendai virus-based human transcriptional gene delivery system fails to reprogram bovine mesenchymal stromal cells (MSC) into induced pluripotent stem cells (iPSC).
Animal Study with a reported sample of 9, published in Mol Biol Rep (2026) — summary generated from the PubMed abstract.
- 2026
- n = 9
Mol Biol Rep - Level DNarrative ReviewPubMed
Adipose-derived mesenchymal stromal cell-microenvironment interaction network in metabolic syndrome: ADMSC injury response, adaptive regulation, and regenerative potential.
Narrative Review on Type 2 Diabetes, Chronic Inflammation, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
Front Cell Dev Biol - Level DAnimal StudyPubMed
Therapeutic potential of adipose-derived mesenchymal stem/stromal cells conditioned medium versus adipose-derived mesenchymal stem/stromal cells on treatment of polycystic ovary In-vivo.
Animal Study on Type 2 Diabetes, published in Tissue Cell (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Cell - Level DAnimal StudyPubMed
Therapeutic potential of three-dimensional hepatocyte-like cells from human adipose-derived mesenchymal stem cells in urea cycle disorders.
Animal Study on Scar, published in Mol Ther (2026) — summary generated from the PubMed abstract.
- 2026
Mol Ther - Level DLaboratory StudyPubMed
Leptin-induced autophagy regulates the immunomodulatory potential of adipose-derived mesenchymal stem cells through down regulating the expression of TSG-6.
Laboratory Study on Immune Modulation, published in Sci Rep (2026) — summary generated from the PubMed abstract.
- 2026
Sci Rep - Level CProspective StudyPubMed
Mesenchymal Stem Cells of Epicardial Adipose Tissue Show Differences in Immunophenotype and Osteogenic Potential in Patients with Coronary and Non-Coronary Heart Disease.
Prospective Study on Cardiovascular Disease, published in Cells (2026) — summary generated from the PubMed abstract.
- 2026
Cells - Level AMeta-analysisPubMed
The Potential Role of Mesenchymal Stem Cell Therapy for Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Human Clinical Trials.
Meta-analysis with a reported sample of 236, published in Stem Cells Dev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 236
Stem Cells Dev - Level DAnimal StudyPubMed
A hydrogel platform delivering mesenchymal stem cell lysate for potential myocardial tissue repair.
Animal Study on Cardiovascular Disease, Chronic Inflammation, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level DAnimal StudyPubMed
Therapeutic potential of mesenchymal stem cells on cholesterol homeostasis-associated genes in AD-like rats.
Animal Study on Neuroinflammation, published in FASEB J (2025) — summary generated from the PubMed abstract.
- 2025
FASEB J - Level BClinical TrialPubMed
Combination of rapamycin and adipose-derived mesenchymal stromal cells enhances therapeutic potential for osteoarthritis.
Clinical Trial on Osteoarthritis, Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther7 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406